KindProtein groupOrganismHumansPharmacological action
Yes
ActionsInhibitor
Blocker
The magnesium regulates the channel gating by binding to the EF-hand motif region in the COOH-terminal tail of the α-subunit of the channel.General FunctionVoltage-gated calcium channel activitySpecific FunctionVoltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hor...
- Brunet S, Scheuer T, Klevit R, Catterall WA: Modulation of CaV1.2 channels by Mg2+ acting at an EF-hand motif in the COOH-terminal domain. J Gen Physiol. 2005 Oct;126(4):311-23. doi: 10.1085/jgp.200509333. Epub 2005 Sep 12. [Article]
- Bara M, Guiet-Bara A: Magnesium regulation of Ca2+ channels in smooth muscle and endothelial cells of human allantochorial placental vessels. Magnes Res. 2001 Mar;14(1-2):11-8. [Article]
- Kuo CC, Hess P: Block of the L-type Ca2+ channel pore by external and internal Mg2+ in rat phaeochromocytoma cells. J Physiol. 1993 Jul;466:683-706. [Article]
- Zhao M, Feng R, Shao D, Liu S, Lei M, Wang H, Sun X, Guo F, Hu H, Kameyama M, Hao L: Mg(2+)-dependent facilitation and inactivation of L-type Ca(2+) channels in guinea pig ventricular myocytes. J Pharmacol Sci. 2015 Nov;129(3):143-9. doi: 10.1016/j.jphs.2015.08.001. Epub 2015 Aug 7. [Article]
- Lin CY, Tsai PS, Hung YC, Huang CJ: L-type calcium channels are involved in mediating the anti-inflammatory effects of magnesium sulphate. Br J Anaesth. 2010 Jan;104(1):44-51. doi: 10.1093/bja/aep336. [Article]
1. Makrides M, Crosby DD, Bain E, Crowther CA. Magnesium supplementation in pregnancy. Cochrane Database Syst Rev. 2014;(4):C:CD000937. [PMC free article] [PubMed] [Google Scholar]
2. McNamara HC, Crowther CA, Brown J. Different treatment regimens of magnesium sulphate for tocolysis in women in preterm labour. Cochrane Database Syst Rev. 2015;12:CD011200. [PMC free article] [PubMed] [Google Scholar]
3. Zaloga GP. Interpretation of the serum magnesium level. Chest. 1989;95:257–8. [PubMed] [Google Scholar]
4. Mepba H, Eboh L, Banigo D. Effects of processing treatments on the nutritive composition and consumer acceptance of some Nigerian edible leafy vegetables. Afr J Food Agric Nutr Dev. 2007;7:1–18. [Google Scholar]
5. Rock CL, Lovalvo JL, Emenhiser C, Ruffin MT, Flatt SW, Schwartz SJ. Bioavailability of beta-carotene is lower in raw than in processed carrots and spinach in women. J Nutr. 1998;128:913–6. [PubMed] [Google Scholar]
6. Seelig MS. Magnesium Deficiency in the Pathogenesis of Disease: Early Roots of Cardiovascular, Skeletal, and Renal Abnormalities. Newyourk, Springer Science and Business Media. 1980 [Google Scholar]
7. Hurley L. Magnesium-deficiency in pregnancy and its effects on the fetus. Magnes Bull. 1981;3:202–8. [Google Scholar]
8. Arikan G, Guecer F, Schoell W, Weiss P. Preterm labour during oral magnesium supplementation in uncomplicated pregnancies. Geburtshilfe Frauenheilkd. 1997;57:491–5. [Google Scholar]
9. Luke B. Nutrition During Pregnancy: Part I, Weight Gain; Part II, Nutrient Supplements. JAMA. 1991;265(2):281–2. [Google Scholar]
10. King DE, Mainous AG, 3rd, Geesey ME, Woolson RF. Dietary magnesium and C-reactive protein levels. J Am Coll Nutr. 2005;24:166–71. [PubMed] [Google Scholar]
11. Becker W, Lyhne N, Pedersen AN, Aro A, Fogelholm M, Phorsdottir I, et al. Nordic nutrition recommendations 2004-integrating nutrition and physical activity. Scand J Nutr. 2004;48:178–87. [Google Scholar]
12. Young VR. Dietary Reference Intakes: For Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington (DC): National Academies Press; 1997. [Google Scholar]
13. Mittendorf R, Dambrosia J, Dammann O, Pryde PG, Lee KS, Ben-Ami TE, et al. Association between maternal serum ionized magnesium levels at delivery and neonatal intraventricular hemorrhage. J Pediatr. 2002;140:540–6. [PubMed] [Google Scholar]
14. Arikan GM, Panzitt T, Gücer F, Scholz HS, Reinisch S, Haas J, et al. Course of maternal serum magnesium levels in low-risk gestations and in preterm labor and delivery. Fetal Diagn Ther. 1999;14:332–6. [PubMed] [Google Scholar]
15. Wynn A, Wynn M. Magnesium and other nutrient deficiencies as possible causes of hypertension and low birthweight. Nutr Health. 1988;6:69–88. [PubMed] [Google Scholar]
16. Harrison V, Fawcus S, Jordaan E. Magnesium supplementation and perinatal hypoxia: Outcome of a parallel group randomised trial in pregnancy. BJOG. 2007;114:994–1002. [PubMed] [Google Scholar]
17. Conradt A, Weidinger H, Algayer H. On the role of magnesium in fetal hypotrophy, pregnancy induced hypertension, and pre-eclampsia. Magnes Bull. 1984;6:68–76. [Google Scholar]
18. Dawson EB, Evans DR, Kelly R, Van Hook JW. Blood cell lead, calcium, and magnesium levels associated with pregnancy-induced hypertension and preeclampsia. Biol Trace Elem Res. 2000;74:107–16. [PubMed] [Google Scholar]
19. Dasgupta S, Ghosh D, Seal SL, Kamilya G, Karmakar M, Saha D. Randomized controlled study comparing effect of magnesium sulfate with placebo on fetal umbilical artery and middle cerebral artery blood flow in mild preeclampsia at=34 weeks gestational age. J Obstet Gynaecol Res. 2012;38:763–71. [PubMed] [Google Scholar]
20. Crowther CA, Brown J, McKinlay CJ, Middleton P. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev. 2014;4:CD001060. [PubMed] [Google Scholar]
21. Ariza AC, Bobadilla N, Fernández C, Muñoz-Fuentes RM, Larrea F, Halhali A. Effects of magnesium sulfate on lipid peroxidation and blood pressure regulators in preeclampsia. Clin Biochem. 2005;38:128–33. [PubMed] [Google Scholar]
22. Alves JG, de Araújo CA, Pontes IE, Guimarães AC, Ray JG. The BRAzil MAGnesium (BRAMAG) trial: A randomized clinical trial of oral magnesium supplementation in pregnancy for the prevention of preterm birth and perinatal and maternal morbidity. BMC Pregnancy Childbirth. 2014;14:222. [PMC free article] [PubMed] [Google Scholar]
23. Abdul MA, Nasir UI, Khan N, Yusuf MD. Low-dose magnesium sulphate in the control of eclamptic fits: A randomized controlled trial. Arch Gynecol Obstet. 2013;287:43–6. [PubMed] [Google Scholar]
24. Spatling LU, Spatling GA. Magnesium supplementation in pregnancy. A double-blind study. Br J Obstet Gynaecol. 1988;95(2):120–5. [PubMed] [Google Scholar]
25. Czeizel AE, Dudás I, Métneki J. Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Final report. Arch Gynecol Obstet. 1994;255:131–9. [PubMed] [Google Scholar]
26. Roman A, Desai N, Rochelson B, Gupta M, Solanki M, Xue X, et al. Maternal magnesium supplementation reduces intrauterine growth restriction and suppresses inflammation in a rat model. Am J Obstet Gynecol. 2013;208:383.e1–7. [PubMed] [Google Scholar]
27. de Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in man: Implications for health and disease. Physiol Rev. 2015;95:1–46. [PubMed] [Google Scholar]
28. Duley L, Gülmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev. 2010;11:CD000025. [PMC free article] [PubMed] [Google Scholar]
29. McDonald SD, Lutsiv O, Dzaja N, Duley L. A systematic review of maternal and infant outcomes following magnesium sulfate for pre-eclampsia/eclampsia in real-world use. Int J Gynaecol Obstet. 2012;118:90–6. [PubMed] [Google Scholar]
30. Shaikh K, Das CM, Baloch GH, Abbas T, Fazlani K, Jaffery MH, et al. Magnesium associated complications in pregnant women. World Appl Sci J. 2012;17:1074–8. [Google Scholar]
31. Doyle W, Crawford MA, Wynn AH, Wynn SW. Maternal magnesium intake and pregnancy outcome. Magnes Res. 1989;2:205–10. [PubMed] [Google Scholar]
32. Franz KB. Magnesium intake during pregnancy. Magnesium. 1987;6:18–27. [PubMed] [Google Scholar]
33. Liu FL, Zhang YM, Parés GV, Reidy KC, Zhao WZ, Zhao A, et al. Nutrient intakes of pregnant women and their associated factors in eight cities of China: A cross-sectional study. Chin Med J (Engl) 2015;128:1778–86. [PMC free article] [PubMed] [Google Scholar]
34. Schoenaker DA, Soedamah-Muthu SS, Mishra GD. The association between dietary factors and gestational hypertension and pre-eclampsia: A systematic review and meta-analysis of observational studies. BMC Med. 2014;12:157. [PMC free article] [PubMed] [Google Scholar]
35. Sibai BM, Villar MA, Bray E. Magnesium supplementation during pregnancy: A double-blind randomized controlled clinical trial. Am J Obstet Gynecol. 1989;161:115–9. [PubMed] [Google Scholar]
36. Rylander R, Vormann J. Magnesium intervention studies-methodological aspects. Magnes Res. 2015;28:75–8. [PubMed] [Google Scholar]
37. Bullarbo M, Ödman N, Nestler A, Nielsen T, Kolisek M, Vormann J, et al. Magnesium supplementation to prevent high blood pressure in pregnancy: A randomised placebo control trial. Arch Gynecol Obstet. 2013;288:1269–74. [PubMed] [Google Scholar]
38. Rudnicki M, Frölich A, Rasmussen WF, McNair P. The effect of magnesium on maternal blood pressure in pregnancy-induced hypertension. A randomized double-blind placebo-controlled trial. Acta Obstet Gynecol Scand. 1991;70:445–50. [PubMed] [Google Scholar]
39. Kovács L, Molnár BG, Huhn E, Bódis L. Magnesium substitution in pregnancy. A prospective, randomized double-blind study. Geburtshilfe Frauenheilkd. 1988;48:595–600. [PubMed] [Google Scholar]
40. Zarcone R, Cardone G, Bellini P. Role of magnesium in pregnancy. Panminerva Med. 1994;36:168–70. [PubMed] [Google Scholar]
Page 2
Baseline characteristics of study population